Singing for lung health following completion of pulmonary rehabilitation: feasibility of a randomised controlled trial.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lewis Adam, Jung Peter, Williams Parris, Steinmann Jennifer, Ingram Karen A, Longley Noah, Trivedi Puja, Clarke Stuart, Lammin Helen, Edwards George, Koulopoulou Maria, Sureshkumar Arun, Moore Anna, Pfeffer Paul E, Reardon Leanne, Sorley Kim, Kenman Jarvis, DeLuca Brendan, Maguire Michelle, Smith Laura-Jane, Elkin Sarah, Lound Adam, Moth Laura, Rickman Penelope, Alexander Sharon, Lohan Natasha, Garsin Emily, Young Susan, Harris Amanda, Watters Rosie, Lane Cleo, Nolan Claire M, Conway Joy, Man William D-C, Banya Winston, Anokye Nana, Philip Keir Elmslie James, Cave Phoene, Hopkinson Nicholas S
Аннотация
METHODS: In a multicentre, mixed-methods randomised controlled feasibility trial, PR participants at four sites were prescreened at baseline assessment. An SLH taster session was included routinely as part of the PR programmes. Eligible PR completers were invited to take part in the trial and randomised to usual care or a 12-week SLH course. Feasibility outcomes included recruitment rate, intervention compliance (at least 8/12 sessions) and health economic analysis. Interviews with participants and study personnel were undertaken and thematic analysis of the results was completed.
RESULTS: Between October 2022 and November 2023, 1311 patients were assessed to start PR, 838 completed. Of those completing, 243 were ineligible to take part (predominantly due to vaccination status and excluded diagnoses for PR referral), and 531 declined. 64 people (33 female, mean (SD) age 69 (12), 41 ethnically white, 33 with chronic obstructive pulmonary disease, 16 with asthma, 9 with interstitial lung disease, 6 with bronchiectasis) were recruited, with 30 (93.8%) SLH and 29 (90.6%) controls completing the study. 20 (62.5%) of the SLH group completed at least 8/12 SLH sessions. There was enthusiasm for a definitive trial from participants, clinicians and singing group leaders' perspectives, based on positive experiences of trial involvement. Improvements to recruitment strategy, intervention structure, outcome measures and staffing were suggested.
CONCLUSIONS: A definitive randomised controlled trial of SLH post-PR appears feasible, with acceptable uptake and completion rates.
TRIAL REGISTRATION NUMBER: ISRCTN11056049.